Eli Lilly is expanding care offerings on its direct-to-consumer (DTC) platform LillyDirect, now offering connections to ...

Topline results were announced from a phase 3 trial evaluating simufilam, an oral small molecule that targets the filamin A protein, for the treatment of mild to moderate Alzheimer disease (AD).

Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...

New research reveals that Type 2 diabetes may impair the brain’s reward and memory processing in ways that mirror early Alzheimer’s disease.

In the first arrangement of its kind, Eli Lilly to connect patients through telemedicine to providers of Alzheimer’s drugs.

Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

Researchers at Boise State University are developing a virtual reality headset that monitors how well users detect certain ...

Witnesses warned canceling projects in midstream could waste years of research data and drive away a generation of young ...

Alzheimer’s disease is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like changes in sleep, anxiety and depression can be early signs of the disease.

FRANKFORT — Kentucky is investing $300,000 into space research that Senate President Robert Stivers said sets the state up as “a leader in all areas.” ...

Alzamend Neuro announced the completion of a device designed by Tesla Dynamic Coils, to monitor lithium levels in the brain, which will help researchers identify therapeutic target doses for a range ...

A new study has found faster accumulation of tau -- a key indicator of Alzheimer's disease -- in the brains of women over the age of 70 who took menopausal hormone therapy (HT) more than a decade ...